These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21253549)

  • 1. In Vitro Activity of Geldanamycin Derivatives against Schistosoma japonicum and Brugia malayi.
    Wenkert D; Ramirez B; Shen Y; Kron MA
    J Parasitol Res; 2010; 2010():716498. PubMed ID: 21253549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reaction of geldanamycin and C17-substituted analogues with glutathione: product identifications and pharmacological implications.
    Cysyk RL; Parker RJ; Barchi JJ; Steeg PS; Hartman NR; Strong JM
    Chem Res Toxicol; 2006 Mar; 19(3):376-81. PubMed ID: 16544941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives.
    Kim T; Keum G; Pae AN
    Expert Opin Ther Pat; 2013 Aug; 23(8):919-43. PubMed ID: 23641970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin.
    Schulte TW; Neckers LM
    Cancer Chemother Pharmacol; 1998; 42(4):273-9. PubMed ID: 9744771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HSP90 inhibitor 17-AAG induced calcium-mediated apoptosis in filarial parasites.
    Ahmad F; Sharma S; Yadav S; Rathaur S
    Drug Dev Res; 2022 Dec; 83(8):1867-1878. PubMed ID: 36219508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress plays a critical role in inactivating mutant BRAF by geldanamycin derivatives.
    Fukuyo Y; Inoue M; Nakajima T; Higashikubo R; Horikoshi NT; Hunt C; Usheva A; Freeman ML; Horikoshi N
    Cancer Res; 2008 Aug; 68(15):6324-30. PubMed ID: 18676857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzoquinone ansamycin heat shock protein 90 inhibitors modulate multiple functions required for tumor angiogenesis.
    Sanderson S; Valenti M; Gowan S; Patterson L; Ahmad Z; Workman P; Eccles SA
    Mol Cancer Ther; 2006 Mar; 5(3):522-32. PubMed ID: 16546966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox properties and thiol reactivity of geldanamycin and its analogues in aqueous solutions.
    Samuni A; Goldstein S
    J Phys Chem B; 2012 Jun; 116(22):6404-10. PubMed ID: 22591491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of geldanamycin analogs against human cancer cells.
    Li YP; Chen JJ; Shen JJ; Cui J; Wu LZ; Wang Z; Li ZR
    Cancer Chemother Pharmacol; 2015 Apr; 75(4):773-82. PubMed ID: 25681003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative.
    Hollingshead M; Alley M; Burger AM; Borgel S; Pacula-Cox C; Fiebig HH; Sausville EA
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):115-25. PubMed ID: 15791458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and induces apoptosis and differentiation of Bcr-Abl-positive human leukemic blasts.
    Nimmanapalli R; O'Bryan E; Bhalla K
    Cancer Res; 2001 Mar; 61(5):1799-804. PubMed ID: 11280726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the EF-2 kinase/Hsp90 protein complex: a possible mechanism to inhibit glioblastoma by geldanamycin.
    Yang J; Yang JM; Iannone M; Shih WJ; Lin Y; Hait WN
    Cancer Res; 2001 May; 61(10):4010-6. PubMed ID: 11358819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted cancer therapy through 17-DMAG as an Hsp90 inhibitor: Overview and current state of the art.
    Mellatyar H; Talaei S; Pilehvar-Soltanahmadi Y; Barzegar A; Akbarzadeh A; Shahabi A; Barekati-Mowahed M; Zarghami N
    Biomed Pharmacother; 2018 Jun; 102():608-617. PubMed ID: 29602128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin in human liver microsomes.
    Zheng N; Zou P; Wang S; Sun D
    Drug Metab Dispos; 2011 Apr; 39(4):627-35. PubMed ID: 21177985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin abrogates the geldanamycin-induced heat shock response.
    McCollum AK; Lukasiewicz KB; Teneyck CJ; Lingle WL; Toft DO; Erlichman C
    Mol Cancer Ther; 2008 Oct; 7(10):3256-64. PubMed ID: 18852129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of heat shock protein 90 destabilizes receptor tyrosine kinase ROR1 in lung adenocarcinoma.
    Khaledian B; Taguchi A; Shin-Ya K; Kondo-Ida L; Kagaya N; Suzuki M; Kajino T; Yamaguchi T; Shimada Y; Takahashi T
    Cancer Sci; 2021 Mar; 112(3):1225-1234. PubMed ID: 33370472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro and In Silico Studies of Glycyrrhetinic Acid Derivatives as Anti- Filarial Agents.
    Tyagi R; Verma S; Mishra S; Srivastava M; Alam S; Khan F; Srivastava SK
    Curr Top Med Chem; 2019; 19(14):1191-1200. PubMed ID: 31210109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of novel Geldanamycin analogue hsp90 alpha-inhibitor in silico for breast cancer therapy.
    Mahanta S; Pilla S; Paul S
    Med Hypotheses; 2013 Sep; 81(3):463-9. PubMed ID: 23860250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex.
    Stravopodis DJ; Margaritis LH; Voutsinas GE
    Curr Med Chem; 2007; 14(29):3122-38. PubMed ID: 18220746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsp90 inhibitor geldanamycin and its derivatives as novel cancer chemotherapeutic agents.
    Miyata Y
    Curr Pharm Des; 2005; 11(9):1131-8. PubMed ID: 15853661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.